Inflammatory and hemostatic response to cardiopulmonary bypass in pediatric population: Feasibility of seriological testing of multiple biomarkers

Artificial Organs

Volumn 34, Issue 11, 2010, Pages 987-995

  Aĝirbaşli, Mehmet ^a   Nguyen, My Le ^b   Win, Khin ^b   Kunselman, Allen R ^b   Clark, J Brian ^b   Myers, John L ^b   Ündar, Akif ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b PENN STATE CHILDREN S HOSPITAL   (United States)

Author keywords

Biomarkers; Multianalyte profiling; Pediatric cardiopulmonary bypass

Indexed keywords

CARDIOLOGY; CARDIOVASCULAR SURGERY; FATTY ACIDS; HEART; PATHOLOGY; PEDIATRICS; PROTEINS; TISSUE;

CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; FATTY ACID-BINDING PROTEINS; MULTI-ANALYTES; MULTIANALYTE PROFILING; MULTIPLE BIOMARKERS; MYELOPEROXIDASE; PEDIATRIC CARDIOPULMONARY BYPASS; TIME POINTS; TISSUE DAMAGE;

BIOMARKERS;

ADIPONECTIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; BETA 2 MICROGLOBULIN; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; COMPLEMENT COMPONENT C3; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; FERRITIN; INSULIN; INTERLEUKIN 16; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; MYOGLOBIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RANTES; THYROTROPIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ARTICLE; BLOOD SAMPLING; CALCITONIN BLOOD LEVEL; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; COMPLEMENT BLOOD LEVEL; CYTOKINE RESPONSE; DISEASE MARKER; ENZYME BLOOD LEVEL; FEASIBILITY STUDY; HEART MUSCLE INJURY; HEMOSTASIS; HUMAN; IMMUNE RESPONSE; INFANT; INFLAMMATION; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

EID: 78649569355     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01133.x     Document Type: Article

References (11)

1. Jenkins KJ. Risk adjustment for congenital heart surgery: the RACHS-1 method. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004;7:180-4.
2. Lull ME, Carkaci-Salli N, Freeman WM, et al. Plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass. Pediatr Res 2008;63:638-44.
3. Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 2006;27:408-13.
4. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardilthorac Surg 2002;21:232-44.
5. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82.
6. Rizzo G, Silvestri E, Capponi A, et al. Histomorphometric characteristics of first trimester chorionic villi in pregnancies with low serum pregnancy-associated plasma protein-A levels: relationship with placental three-dimensional power Doppler ultrasonographic vascularization. J Matern Fetal Neonatal Med 2010 (Epub ahead of print) PMID: 20459339.
7. Lund J, Wittfooth S, Qin QP, et al. Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with Non-ST-elevation acute coronary syndrome. Clin Chem 2010;56:1158-65.
8. Iversen KK, Dalsgaard M, Teisner AS, et al. Pregnancy-associated plasma protein-a, a marker for outcome in patients suspected for acute coronary syndrome. Clin Biochem 2010;43:851-7.
9. Baldus S, Heeschen C, Meinertz T, et al.; CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440-5.
10. Hasegawa T, Yamaguchi M, Yoshimura N, Okita Y. The dependence of myocardial damage on age and ischemic time in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2005;129:192-8.
11. Hasegawa T, Yoshimura N, Oka S, Ootaki Y, Toyoda Y, Yamaguchi M. Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2004;127:1697-702.